Efficacy of Infliximab on the acute attack of uveitis

Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when us...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Saudi medical journal 2010, Vol.31 (1), p.82-85
Hauptverfasser:	ALOKAILY, Fahdah, ALSALEH, Sulaiman, AL-BALAWI, Maryseon, AL-RASHIDI, Seham
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Behcet Syndrome - complications Biological and medical sciences Female General aspects Humans Immunomodulators Infliximab Male Medical sciences Ophthalmology Pharmacology. Drug treatments Treatment Outcome Uvea diseases Uveitis - drug therapy Uveitis - etiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	85
container_issue	1
container_start_page	82
container_title	Saudi medical journal
container_volume	31
creator	ALOKAILY, Fahdah ALSALEH, Sulaiman AL-BALAWI, Maryseon AL-RASHIDI, Seham
description	Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733705006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733705006</sourcerecordid><originalsourceid>FETCH-LOGICAL-p240t-5f32d8508e042e399e0b5b35a07e636612840fee263f36b3c60f9c5cf492db273</originalsourceid><addsrcrecordid>eNpFz09LxDAQBfAcFHdd_QrSi3gqjJkmbY6yrLqw4EXPJUknGO0_m1Tcb2_EipeZy4_HeydsDViqXPCqWLHzEN4AUEqQZ2zFASRXINdM7JzzVttjNrhs37vWf_lOm2zos_hKmbZzTDdGbd9_xPxJPvpwwU6dbgNdLn_DXu53z9vH_PD0sN_eHfKRFxBz4ZA3lYCKoOCEShEYYVBoKEmmLrepGjgiLtGhNGglOGWFdYXijeElbtjNb-44DR8zhVh3PlhqW93TMIe6RCxBpDFJXi1yNh019TilGdOx_luawPUCdLC6dZPurQ__jouUowR-AwI1WTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733705006</pqid></control><display><type>article</type><title>Efficacy of Infliximab on the acute attack of uveitis</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>ALOKAILY, Fahdah ; ALSALEH, Sulaiman ; AL-BALAWI, Maryseon ; AL-RASHIDI, Seham</creator><creatorcontrib>ALOKAILY, Fahdah ; ALSALEH, Sulaiman ; AL-BALAWI, Maryseon ; AL-RASHIDI, Seham</creatorcontrib><description>Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.</description><identifier>ISSN: 0379-5284</identifier><identifier>PMID: 20062906</identifier><identifier>CODEN: SAMJDI</identifier><language>eng</language><publisher>Riyadh: Saudi Medical Journal</publisher><subject>Acute Disease ; Adult ; Anti-Inflammatory Agents - therapeutic use ; Antibodies, Monoclonal - therapeutic use ; Behcet Syndrome - complications ; Biological and medical sciences ; Female ; General aspects ; Humans ; Immunomodulators ; Infliximab ; Male ; Medical sciences ; Ophthalmology ; Pharmacology. Drug treatments ; Treatment Outcome ; Uvea diseases ; Uveitis - drug therapy ; Uveitis - etiology ; Young Adult</subject><ispartof>Saudi medical journal, 2010, Vol.31 (1), p.82-85</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22550095$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20062906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALOKAILY, Fahdah</creatorcontrib><creatorcontrib>ALSALEH, Sulaiman</creatorcontrib><creatorcontrib>AL-BALAWI, Maryseon</creatorcontrib><creatorcontrib>AL-RASHIDI, Seham</creatorcontrib><title>Efficacy of Infliximab on the acute attack of uveitis</title><title>Saudi medical journal</title><addtitle>Saudi Med J</addtitle><description>Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Behcet Syndrome - complications</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Infliximab</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Pharmacology. Drug treatments</subject><subject>Treatment Outcome</subject><subject>Uvea diseases</subject><subject>Uveitis - drug therapy</subject><subject>Uveitis - etiology</subject><subject>Young Adult</subject><issn>0379-5284</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFz09LxDAQBfAcFHdd_QrSi3gqjJkmbY6yrLqw4EXPJUknGO0_m1Tcb2_EipeZy4_HeydsDViqXPCqWLHzEN4AUEqQZ2zFASRXINdM7JzzVttjNrhs37vWf_lOm2zos_hKmbZzTDdGbd9_xPxJPvpwwU6dbgNdLn_DXu53z9vH_PD0sN_eHfKRFxBz4ZA3lYCKoOCEShEYYVBoKEmmLrepGjgiLtGhNGglOGWFdYXijeElbtjNb-44DR8zhVh3PlhqW93TMIe6RCxBpDFJXi1yNh019TilGdOx_luawPUCdLC6dZPurQ__jouUowR-AwI1WTA</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>ALOKAILY, Fahdah</creator><creator>ALSALEH, Sulaiman</creator><creator>AL-BALAWI, Maryseon</creator><creator>AL-RASHIDI, Seham</creator><general>Saudi Medical Journal</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Efficacy of Infliximab on the acute attack of uveitis</title><author>ALOKAILY, Fahdah ; ALSALEH, Sulaiman ; AL-BALAWI, Maryseon ; AL-RASHIDI, Seham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p240t-5f32d8508e042e399e0b5b35a07e636612840fee263f36b3c60f9c5cf492db273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Behcet Syndrome - complications</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Infliximab</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Pharmacology. Drug treatments</topic><topic>Treatment Outcome</topic><topic>Uvea diseases</topic><topic>Uveitis - drug therapy</topic><topic>Uveitis - etiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALOKAILY, Fahdah</creatorcontrib><creatorcontrib>ALSALEH, Sulaiman</creatorcontrib><creatorcontrib>AL-BALAWI, Maryseon</creatorcontrib><creatorcontrib>AL-RASHIDI, Seham</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Saudi medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALOKAILY, Fahdah</au><au>ALSALEH, Sulaiman</au><au>AL-BALAWI, Maryseon</au><au>AL-RASHIDI, Seham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Infliximab on the acute attack of uveitis</atitle><jtitle>Saudi medical journal</jtitle><addtitle>Saudi Med J</addtitle><date>2010</date><risdate>2010</risdate><volume>31</volume><issue>1</issue><spage>82</spage><epage>85</epage><pages>82-85</pages><issn>0379-5284</issn><coden>SAMJDI</coden><abstract>Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.</abstract><cop>Riyadh</cop><pub>Saudi Medical Journal</pub><pmid>20062906</pmid><tpages>4</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0379-5284
ispartof	Saudi medical journal, 2010, Vol.31 (1), p.82-85
issn	0379-5284
language	eng
recordid	cdi_proquest_miscellaneous_733705006
source	MEDLINE; EZB Electronic Journals Library
subjects	Acute Disease Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Behcet Syndrome - complications Biological and medical sciences Female General aspects Humans Immunomodulators Infliximab Male Medical sciences Ophthalmology Pharmacology. Drug treatments Treatment Outcome Uvea diseases Uveitis - drug therapy Uveitis - etiology Young Adult
title	Efficacy of Infliximab on the acute attack of uveitis
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Infliximab%20on%20the%20acute%20attack%20of%20uveitis&rft.jtitle=Saudi%20medical%20journal&rft.au=ALOKAILY,%20Fahdah&rft.date=2010&rft.volume=31&rft.issue=1&rft.spage=82&rft.epage=85&rft.pages=82-85&rft.issn=0379-5284&rft.coden=SAMJDI&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E733705006%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733705006&rft_id=info:pmid/20062906&rfr_iscdi=true